?? Future of Omics Interview Highlight ?? We had the pleasure of speaking with Prof Christian Conrad from the Berlin Institute of Health at Charité - Universit?tsmedizin Berlin! Prof. Conrad shared his valuable insights and experiences with Stereo-seq technology, MGI's FluoXpert, and MGI Hong Kong aLab and had high praise for each of these tools in supporting breakthrough research. Thank you, Prof. Conrad, for your remarkable work and continued trust in MGI! #FutureofOmics #seqALL #Stereoseq
MGI的动态
最相关的动态
-
From AI-designed drugs to futuristic cryo-preservation, Alex Zhavoronkov, Founder & CEO at Insilico Medicine shares how Insilico Medicine is working on breakthroughs that could reshape both healthcare and material science. ???? ?? https://lnkd.in/gsuuMjTg This episode was created in collaboration with HumanX. #AIDrugDiscovery #SliceofTechnologyAI #SoTPodcasts
-
Grab your slice of AI expertise! Tune into the latest Slice of Technology interview featuring HumanX speaker Alex Zhavoronkov and learn how AI can positively impact healthcare and material sciences.
From AI-designed drugs to futuristic cryo-preservation, Alex Zhavoronkov, Founder & CEO at Insilico Medicine shares how Insilico Medicine is working on breakthroughs that could reshape both healthcare and material science. ???? ?? https://lnkd.in/gsuuMjTg This episode was created in collaboration with HumanX. #AIDrugDiscovery #SliceofTechnologyAI #SoTPodcasts
-
What role can ecosystems play in supporting the growth of precision medicine? ?? Effective community and collaboration is key to enable ongoing research and development milestones in precision medicine, and our life science and tech clusters are created to support this. Through our growing network of customers, and clinical and academic partners, businesses at Alderley Park and Citylabs can take advantage of an environment designed to support their success. Our latest whitepaper with Drug Discovery World explores how precision medicine is reshaping healthcare and driving forward the next generation of treatments, as well as the essential role of establishing ecosystems to power progress. Read it here: bit.ly/3XQ26XP
-
-
Last chance to register! ?? https://buff.ly/3XmDSEj Join us at 2pm BST for a discussion around moving compounds to IND using predictive retina models?? #Newcells #VisionResearch #Retina #PredictiveModels
Our next webinar takes place tomorrow! ? ?? Moving compounds to IND using predictive retina models Our expert panelists will share their insights from Regulatory, Technology, and Scientific Perspectives. They will also delve into strategies for streamlining the clinical development pipeline, with a special focus on retina-related compounds. ??Speakers: Dr Lauren E. Black - Distinguished Scientist/Consultant, working mainly at the first in human (FIH) stage - in high-risk diseases using novel products at Charles River Laboratories Dr Roxana Redis - Associate Science Director, leading the development of the ASO hit to lead platform within Early Discovery at Charles River Laboratories Dr Valeria Chichagova, PhD - Director of Technology, Newcells Biotech ?? June 19th - 2:00 PM BST Find out more and register here: https://buff.ly/3XmDSEj #Newcells #VisionResearch #Retina #PredictiveModels
-
-
?? Get an insider’s perspective on FORCE REPAIR Wounds from our partner Histocell. Regenerative Medicine! In our latest FORCE REPAIR video, Bego?a Castro shares how Histocell. Regenerative Medicine is driving innovation in chronic wound management - supporting the development and manufacturing of advanced medical devices for hard-to-heal wounds. ?? The video was filmed at last year’s #EWMA conference, presented as we prepare for EWMA 2025 in Barcelona (26–28 March , 2025). ??? Watch the full video here: https://lnkd.in/d9tHk4SQ #EWMA2024 #EWMA2025 #FORCEREPAIR #Innovation #HorizonEU
-
-
In the rapidly evolving landscape of advanced medicine, the journey from lab bench to patient bedside has become more critical—and complex—than ever before. As therapy developers continue to push the boundaries of what is possible, the role of transport, logistics, and storage specialists has grown increasingly vital in ensuring that these groundbreaking therapies reach patients safely and effectively. How can these two sectors collaborate more effectively? What are the latest trends and challenges in cryopreservation that are shaping the future of medicine? Likarda CEO Stella K. Vnook joined other industry experts, Priya Baraniak, Ph.D. (OrganaBio) and Trevor Smith (Terumo Blood and Cell Technologies), for an insightful panel discussion hosted by The Medicine Maker where they explored these critical questions and more. Gain valuable insights into how innovative collaborations and cutting-edge cryopreservation technologies are paving the way for the next generation of advanced therapies. ?Watch the full discussion here:?https://lnkd.in/gBQjWgSG #advancedmedicine #healthcareinnovation #cryopreservation #celltherapy
-
-
Update from the lab of Professor @Ygal Rottenstrich and Dr. Ifat Sher at Sheba Medical Center, Tel Hashomer: First results of the study of #ExoPTEN for #glaucoma are expected soon. Stay tuned. Thanks to Professor Michael Belkin for initiating this important work!
-
?? Wyss Center invests CHF 750,000 in dEEGtal The Wyss Center for Bio and Neuroengineering supports dEEGtal Insight SA, an innovative spin-off from Université de Genève and HUG - H?pitaux Universitaires de Genève. Using AI-powered technology, dEEGtal Insight simplifies EEG analysis and enhances epilepsy detection for faster, more accurate diagnoses. Wyss Center Director Erwin B?ttinger states: "This partnership underscores our commitment to impactful healthcare innovation." Congratulations Eric Ménétré, Stefano Gallotto & Prof. Margitta Seeck https://lnkd.in/e3RCM3it #HealthcareInnovation #EpilepsyDiagnosis #AIinMedicine
-
-
#UCIAlumni David Cuccia '02, M.S. '03, Ph.D. '06 and his company Modulim created a device that is reducing the need for diabetes-related amputations by using light projections to see beneath the skin to detect subtle changes in a diabetic patient’s microvascular circulation. Read on to learn more about this innovation that is changing lives! #UCIPride ?? ??
Will Modulim End the Amputation Epidemic? Modulim, a company born out of UC Irvine's, Beckman Laser Institute is changing lives with cutting-edge imaging technology that enhances blood flow assessment, empowering early intervention to prevent diabetic-related amputations. By enabling precise and non-invasive care, Modulim’s innovation is redefining the potential for health outcomes. Read about Modulim and its innovators: https://bit.ly/41BRHRp Beckman Laser Institute, UCI Samueli School of Engineering, UCI Alumni Association #UCI #diabetes #Innovation
-
-
Imagine a future where healthcare is tailored precisely for you, right down to the molecules deep inside your cells. At the core of this future are "omics" technologies, which measure and analyze various molecules at multiple levels within human organisms, cells and tissues, where many diseases originate. Building on this foundational science, Mayo Clinic’s Center for Individualized Medicine has launched a new "omics" strategy designed to integrate precision medicine into everyday clinical practice. Learn more: https://mayocl.in/4byqIYz
